Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject

NCT00823875 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis Cerebral Infarction

Interventions

DRUG: Cilostazol group
DRUG: Probucol group
DRUG: Cilostazol + Probucol group
DRUG: control group

Sponsor

Otsuka Beijing Research Institute